Australia is making it harder to protect inventions. That’s bad for American businesses and jobs.

Bringing a single new medicine to market requires substantial resources over many years. To ensure continued investment in the development of tomorrow’s breakthrough treatments and cures, innovators...
Read More
New nonprofit – I-ACT for Children – launches to promote innovative medicines development for young patients in need

In an exciting step forward to support research and development of innovative new medicines and devices for pediatric patients, the Critical Path Institute (C-Path) announced the launch of a new...
Read More
PhRMA urges USTR to protect American innovators abroad

Yesterday, PhRMA submitted comments for the 2017 Special 301 Report the Office of the U.S. Trade Representative (USTR) will publish in April. The comments highlight serious intellectual property and...
Read More
Fact Check Friday: The truth about biopharmaceutical patents

MYTH: Biopharmaceutical companies use government-protected monopolies to raise costs on medicines. FACT: Patent-protected medicines routinely face competition from other brand name medicines, which...
Read More
Canada’s promise doctrine strikes again

In just the last few weeks Canada has once again taken steps to invalidate yet another medicine (Zymar®) by applying the “promise doctrine.” See Allergan Inc. v. Apotex Inc., 2016 FC 344 (April 1,...
Read More
Strong IP is propelling innovation and saving lives

Each day, new medicines are being researched and developed that save lives and improve patients’ quality of life. As the global epicenter of life science innovation and technological breakthroughs,...
Read More
World IP Day: Celebrating the protections that allow innovation to thrive

Today is World Intellectual Property Day, a celebration across the globe of the protections that allow creativity, risk-taking and innovation to thrive. America has long been the world’s innovation...
Read More
India denies patent on novel HIV/AIDS medicine

In 2014, several months after Prime Minister Modi took office, he announced an ambitious initiative called “Make in India.” The goal was to encourage foreign and domestic companies to manufacture...
Read More
IP protections found to be critical to life-science innovation and investment

A new report by the Information Technology and Innovation Foundation (ITIF) has found intellectual property (IP) protections to be crucial to stimulating risk-taking and innovation. The study, How...
Read More
Time to enforce the rules that protect American ideas, brands and inventions

Earlier today, PhRMA joined organizations representing every sector of America’s knowledge economy at a public hearing in Washington that will inform the federal government’s annual “Special 301”...
Read More